These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. In vitro activities of daptomycin, vancomycin, quinupristin- dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates. Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT Antimicrob Agents Chemother; 2003 Jan; 47(1):337-41. PubMed ID: 12499210 [TBL] [Abstract][Full Text] [Related]
4. In vitro activities of the new semisynthetic glycopeptide telavancin (TD-6424), vancomycin, daptomycin, linezolid, and four comparator agents against anaerobic gram-positive species and Corynebacterium spp. Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT Antimicrob Agents Chemother; 2004 Jun; 48(6):2149-52. PubMed ID: 15155214 [TBL] [Abstract][Full Text] [Related]
5. In vitro activities of dalbavancin and nine comparator agents against anaerobic gram-positive species and corynebacteria. Goldstein EJ; Citron DM; Merriam CV; Warren Y; Tyrrell K; Fernandez HT Antimicrob Agents Chemother; 2003 Jun; 47(6):1968-71. PubMed ID: 12760876 [TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro activity of LY146032 (daptomycin), a new lipopeptide antimicrobial. Hodinka RL; Jack-Wait K; Wannamaker N; Walden TP; Gilligan PH Eur J Clin Microbiol; 1987 Feb; 6(1):100-3. PubMed ID: 3032607 [TBL] [Abstract][Full Text] [Related]
7. Comparative in-vitro activity of LY146032 a new peptolide, with vancomycin and eight other agents against gram-positive organisms. Benson CA; Beaudette F; Trenholm G J Antimicrob Chemother; 1987 Aug; 20(2):191-6. PubMed ID: 2822645 [TBL] [Abstract][Full Text] [Related]
8. In vitro evaluation of the new paulomycin antibiotic paldimycin. Eliopoulos GM; Reiszner E; Moellering RC Eur J Clin Microbiol; 1987 Jun; 6(3):306-8. PubMed ID: 3622497 [TBL] [Abstract][Full Text] [Related]
9. In vitro activity of vancomycin and teicoplanin against anaerobic bacteria. Robbins MJ; Marais R; Felmingham D; Ridgway GL; Grüneberg RN Drugs Exp Clin Res; 1987; 13(9):551-4. PubMed ID: 2962846 [TBL] [Abstract][Full Text] [Related]
10. In vitro activity of TD-1792, a multivalent glycopeptide-cephalosporin antibiotic, against 377 strains of anaerobic bacteria and 34 strains of Corynebacterium species. Tyrrell KL; Citron DM; Warren YA; Goldstein EJ Antimicrob Agents Chemother; 2012 Apr; 56(4):2194-7. PubMed ID: 22290981 [TBL] [Abstract][Full Text] [Related]
11. In-vitro susceptibility of gram-positive cocci to LY146032 teicoplanin, sodium fusidate, vancomycin, and rifampicin. Pohlod DJ; Saravolatz LD; Somerville MM J Antimicrob Chemother; 1987 Aug; 20(2):197-202. PubMed ID: 2822646 [TBL] [Abstract][Full Text] [Related]
12. In vitro activity of LY146032 against gram-positive bacteria. Silva M; Jacobus NV; Gorbach SL Diagn Microbiol Infect Dis; 1988 Feb; 9(2):79-85. PubMed ID: 2838217 [TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility of gram-positive cocci to paldimycin. Pohlod DJ; Saravolatz LD; Somerville MM Antimicrob Agents Chemother; 1987 Jan; 31(1):104-7. PubMed ID: 3105438 [TBL] [Abstract][Full Text] [Related]
14. In vitro activity of paldimycin (U-70138F) against gram-positive bacteria isolated from patients with cancer. Rolston KV; LeBlanc B; Ho DH; Bodey GP Antimicrob Agents Chemother; 1987 Apr; 31(4):650-2. PubMed ID: 3606069 [TBL] [Abstract][Full Text] [Related]
15. Activity of mersacidin, a novel peptide, compared with that of vancomycin, teicoplanin, and daptomycin. Niu WW; Neu HC Antimicrob Agents Chemother; 1991 May; 35(5):998-1000. PubMed ID: 1649577 [TBL] [Abstract][Full Text] [Related]
16. In vitro activities of daptomycin, vancomycin, and penicillin against Clostridium difficile, C. perfringens, Finegoldia magna, and Propionibacterium acnes. Tyrrell KL; Citron DM; Warren YA; Fernandez HT; Merriam CV; Goldstein EJ Antimicrob Agents Chemother; 2006 Aug; 50(8):2728-31. PubMed ID: 16870765 [TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro activities of XRP 2868, pristinamycin, quinupristin-dalfopristin, vancomycin, daptomycin, linezolid, clarithromycin, telithromycin, clindamycin, and ampicillin against anaerobic gram-positive species, actinomycetes, and lactobacilli. Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT; Bryskier A Antimicrob Agents Chemother; 2005 Jan; 49(1):408-13. PubMed ID: 15616322 [TBL] [Abstract][Full Text] [Related]
18. In vitro activities of daptomycin and other antimicrobial agents against vancomycin-resistant gram-positive bacteria. de la Maza L; Ruoff KL; Ferraro MJ Antimicrob Agents Chemother; 1989 Aug; 33(8):1383-4. PubMed ID: 2552910 [TBL] [Abstract][Full Text] [Related]
19. In vitro activities of ramoplanin, teicoplanin, vancomycin, linezolid, bacitracin, and four other antimicrobials against intestinal anaerobic bacteria. Citron DM; Merriam CV; Tyrrell KL; Warren YA; Fernandez H; Goldstein EJ Antimicrob Agents Chemother; 2003 Jul; 47(7):2334-8. PubMed ID: 12821492 [TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro activities of teicoplanin, daptomycin, ramoplanin, vancomycin, and PD127,391 against blood isolates of gram-positive cocci. Shonekan D; Mildvan D; Handwerger S Antimicrob Agents Chemother; 1992 Jul; 36(7):1570-2. PubMed ID: 1324649 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]